Listen Now

Topics Covered

• Overview & Definition of Biosimilars
• The Difference Between Biosimilars & Generic Drugs
• How Biosimilars Work & Their Use
• Examples of Biosimilars
• Implications in Managing the Cost of Cancer Treatments
• Clinical Trials: How Biosimilar Research Contributes to Treatment Options
• The Benefits of Biosimilars
• Current Use in the Care of People Living with Cancer
• Manufacturing & Safety Issues
• Key Questions to Ask Your Health Care Team About Biosimilars
• Current & Future Perspectives
• Questions for Our Panel of Experts

Our Panel of Experts

Richard J. Gralla, MD, FACP

Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center

Jeffrey Crawford, MD

George Barth Geller Professor for Research in Cancer, Department of Medicine, Duke University School of Medicine, Co-Director, Solid Tumor Therapeutics Program, Duke Cancer Institute

Edward Li, PharmD, MPH, BCOP

Professor, University of New England College of Pharmacy

Carolyn Messner, DSW, OSW-C, FAPOS

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(79 KB)

Workshop Date

This workshop was originally recorded on May 24, 2018.